BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 15011166)

  • 21. An open-label, prospective study of guanfacine in children with ADHD and tic disorders.
    Boon-yasidhi V; Kim YS; Scahill L
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S156-62. PubMed ID: 16856436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder.
    Scahill L; Chappell PB; Kim YS; Schultz RT; Katsovich L; Shepherd E; Arnsten AF; Cohen DJ; Leckman JF
    Am J Psychiatry; 2001 Jul; 158(7):1067-74. PubMed ID: 11431228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased event-related theta activity as a psychophysiological marker of comorbidity in children with tics and attention-deficit/hyperactivity disorders.
    Yordanova J; Heinrich H; Kolev V; Rothenberger A
    Neuroimage; 2006 Aug; 32(2):940-55. PubMed ID: 16730196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment practices in Tourette syndrome: the European perspective.
    Rickards H; Cavanna AE; Worrall R
    Eur J Paediatr Neurol; 2012 Jul; 16(4):361-4. PubMed ID: 22178398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tourette syndrome and chronic tics in a sample of children and adolescents.
    Saccomani L; Fabiana V; Manuela B; Giambattista R
    Brain Dev; 2005 Aug; 27(5):349-52. PubMed ID: 16023550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentary.
    Robertson MM
    Eur Child Adolesc Psychiatry; 2006 Feb; 15(1):1-11. PubMed ID: 16514504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In the pipeline: non-stimulant ADHD meds.
    Glazer WM
    Behav Healthc; 2010 Jan; 30(1):30-1. PubMed ID: 20184258
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical aspects of Tourette syndrome].
    Debes NM; Hjalgrim H; Skov L
    Ugeskr Laeger; 2008 Aug; 170(35):2701-3. PubMed ID: 18761861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does guanfacine trigger mania in children?
    Horrigan JP; Barnhill LJ
    J Child Adolesc Psychopharmacol; 1998; 8(2):149-50. PubMed ID: 9730081
    [No Abstract]   [Full Text] [Related]  

  • 30. Learning difficulties in children with Tourette syndrome.
    Singer HS; Schuerholz LJ; Denckla MB
    J Child Neurol; 1995 Jan; 10 Suppl 1():S58-61. PubMed ID: 7751556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders.
    Steingard R; Biederman J; Spencer T; Wilens T; Gonzalez A
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):350-3. PubMed ID: 8444764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical phenomenology and phenotype variability in Tourette syndrome.
    Grados MA; Mathews CA
    J Psychosom Res; 2009 Dec; 67(6):491-6. PubMed ID: 19913653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the presence of comorbidities in a Danish clinical cohort of children with Tourette syndrome.
    Mol Debes NM; Hjalgrim H; Skov L
    J Child Neurol; 2008 Sep; 23(9):1017-27. PubMed ID: 18827268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome.
    Kompoliti K; Goetz CG
    Mov Disord; 1998 May; 13(3):477-80. PubMed ID: 9613740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guanfacine for Tourette's disorder.
    Fras I
    J Am Acad Child Adolesc Psychiatry; 1996 Jan; 35(1):3-4. PubMed ID: 8567607
    [No Abstract]   [Full Text] [Related]  

  • 36. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders.
    Allen AJ; Kurlan RM; Gilbert DL; Coffey BJ; Linder SL; Lewis DW; Winner PK; Dunn DW; Dure LS; Sallee FR; Milton DR; Mintz MI; Ricardi RK; Erenberg G; Layton LL; Feldman PD; Kelsey DK; Spencer TJ
    Neurology; 2005 Dec; 65(12):1941-9. PubMed ID: 16380617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychopharmacotherapy of Obsessive-Compulsive Symptoms within the Framework of Tourette Syndrome.
    Rothenberger A; Roessner V
    Curr Neuropharmacol; 2019; 17(8):703-709. PubMed ID: 30152283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tic disorders of childhood.
    Clementz GL; Lee RH; Barclay AM
    Am Fam Physician; 1988 Aug; 38(2):163-70. PubMed ID: 3044053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination treatment with guanfacine extended release and blonanserin for Tourette's syndrome comorbid with attention deficit hyperactivity disorder.
    Kawabe K; Horiuchi F; Ueno SI
    Psychiatry Clin Neurosci; 2019 Dec; 73(12):762-763. PubMed ID: 31588606
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacotherapy for tics in adult patients with Tourette syndrome and other tic disorders.
    Badenoch J; Cavanna AE
    Neurol Sci; 2020 Jul; 41(7):1923-1926. PubMed ID: 32170503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.